Ana Rebeca Jaloma Cruz. https://orcid.org/0000-0002-3853-1283Head Researcher at Genetics Department of the Biomedical Research Center of Western Mexico, from the Mexican Institute of Social Security (Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, in Guadalajara, Jalisco, Mexico.Dr. Ana Rebeca Jaloma Cruz holds a Ph.D. in Human Genetics from University of Guadalajara. Her research experience deals with the genetic analysis of inherited clotting disorders, mainly focusing on Hemophilia, von Willebrand disease and Thrombophilia. Her scientific productivity includes 29 international scientific publications with 488 citations, and three book chapters. She is member of the Mexican Group for Hematology Study (AMEH) and of the Cooperative Latin American Group of Hemostasis and Thrombosis (CLAHT). She is medical adviser for the national organization of hemophilia patients’ society in Mexico and has been recognized as a National Researcher since 1999, with her current distinction as SNI level 2.
Research Keywords & Expertise
von Willebrand disease
genotype-phenotype
thrombosis
gene therapy
molecular diagnostics
hemophilia
human genetics
clotting disorders
Fingerprints
48%
hemophilia
12%
von Willebrand disease
12%
gene therapy
Short Biography
Ana Rebeca Jaloma Cruz. https://orcid.org/0000-0002-3853-1283Head Researcher at Genetics Department of the Biomedical Research Center of Western Mexico, from the Mexican Institute of Social Security (Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, in Guadalajara, Jalisco, Mexico.Dr. Ana Rebeca Jaloma Cruz holds a Ph.D. in Human Genetics from University of Guadalajara. Her research experience deals with the genetic analysis of inherited clotting disorders, mainly focusing on Hemophilia, von Willebrand disease and Thrombophilia. Her scientific productivity includes 29 international scientific publications with 488 citations, and three book chapters. She is member of the Mexican Group for Hematology Study (AMEH) and of the Cooperative Latin American Group of Hemostasis and Thrombosis (CLAHT). She is medical adviser for the national organization of hemophilia patients’ society in Mexico and has been recognized as a National Researcher since 1999, with her current distinction as SNI level 2.
Advance your academic career, collaborate globally, and expand your network—
join now
!
Well done!
